The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth

It is well established that Cholangiocarcioma (CCA) drug resistance plays a crucial role in the spread and survival of cancer cells. The major enzyme in the nicotinamide-adenine dinucleotide (NAD+)-mediated pathways, nicotinamide phosphoribosyltransferase (NAMPT), is essential for cancer cell surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Pant, Kishor, Richard, Seth, Peixoto, Estanislao, Yin, Jun, Seelig, Davis M., Carotenuto, Pietro, Salati, Massimiliano, Franco, Brunella, Roberts, Lewis R., Gradilone, Sergio A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001024/
https://www.ncbi.nlm.nih.gov/pubmed/36899911
http://dx.doi.org/10.3390/cells12050775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001024/
https://www.ncbi.nlm.nih.gov/pubmed/36899911
http://dx.doi.org/10.3390/cells12050775

Ejemplares similares